Advertisement

Topics

Eli Lilly and Company Limited Company Profile

19:13 EST 22nd November 2017 | BioPortfolio


News Articles [677 Associated News Articles listed on BioPortfolio]

Eli Lilly and Company Strategy, SWOT and Corporate Finance Report [Report Updated: 03082017] Prices from USD $175

Eli Lilly and Company Strategy, SWOT and Corporate Finance ReportSummaryEli Lilly and Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. ...

Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement

INDIANAPOLIS, Oct. 2, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2017 on Tuesday, October 24, 2017. Lilly will also conduc...

Evonik, Lilly renew APIs & intermediates supply agreement

Evonik Industries and Eli Lilly and Company (Lilly) announced the renewal of a long─term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use i...

Pro-Trader Daily: Featured Company News - Eli Lilly Achieves Positive Results for Second Phase-3 Study of Lasmiditan, an Acute Migraine Treatment

LONDON, UK / ACCESSWIRE / August 7, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Eli Lilly & Co. (NYSE: LLY) ("Eli Lilly"), following which ...

Pro-Trader Daily: Featured Company News - Eli Lilly Announces That Verzenio Failed To Meet Primary Endpoint of Overall Survival in Phase-3 JUNIPER Study

LONDON, UK / ACCESSWIRE / October 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Eli Lilly and Co. (NYSE: LLY) ("Eli Lilly"), following wh...

Topas Therapeutics inks research agreement with Eli Lilly on immune tolerance

Topas Therapeutics GmbH, a Hamburg, Germany─based private company, has announced that it has signed a multi─year agreement with Eli Lilly and Company (Lilly) to collaborate in the field of antigen...

Drugmaker Lilly beats Street 2Q forecasts, raises outlook

This Tuesday, July 17, 2012, file photo shows the Eli Lilly corporate headquarters in Indianapolis. Eli Lilly and Co.

Eli Lilly To Present Data From Phase 3 Studies Of Abemaciclib, Ramucirumab

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) announced it will showcase new data across six different tumor types at the European Society for Medical Oncology 2017 Congress in Madrid, Spai...

Drugs and Medications [1332 Associated Drugs and Medications listed on BioPortfolio]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Ranitidine [WOCKHARDT LIMITED]

Ranitidine [WOCKHARDT LIMITED]

Drug Facts

Famotidine [WOCKHARDT LIMITED]

Famotidine Tablets, USP 20 mg

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Abemaciclib: First Global Approval.

Abemaciclib (Verzenio™) is an orally administered inhibitor of cyclin-dependent kinases 4 and 6 that is being developed by Eli Lilly and Company. Abemaciclib has been approved in the USA for the tre...

Editorial: In Good Company.

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

What do company health insurance plans provide?

Company health insurance plans are a voluntary employer benefit and an increasingly important part of company pension and benefits systems. They enable employers to invest in the health of their emplo...

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Clinical Trials [84 Associated Clinical Trials listed on BioPortfolio]

An Open Label Study of Oral Enzastaurin in Patients With Cancer

This study will collect further basic safety data on patients with cancer treated with enzastaurin. This study is not open to the public. The purpose of the this study is to extend the c...

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania

Inpatient Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Mania: This study recruits adult subjects who are diagnosed with Bip...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Companies [1502 Associated Companies listed on BioPortfolio]

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

More Information about "Eli Lilly and Company Limited" on BioPortfolio

We have published hundreds of Eli Lilly and Company Limited news stories on BioPortfolio along with dozens of Eli Lilly and Company Limited Clinical Trials and PubMed Articles about Eli Lilly and Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eli Lilly and Company Limited Companies in our database. You can also find out about relevant Eli Lilly and Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record